PATH's Malaria Control Program

Our featured projects

Malaria Control and Elimination Partnership in Africa (MACEPA)

The Malaria Control and Elimination Partnership in Africa (MACEPA), a program at PATH, serves as a global resource to national governments and the Roll Back Malaria Partnership. It works on the front lines of country-level malaria elimination efforts, developing and documenting new approaches based on national experiences and sharing these tools with country partners through trainings, meetings, and other shared learning platforms.

PATH also developed the Making Malaria History website, a resource for the global malaria community to provide updates on the latest malaria research and news, provide advocates with timely data and resources, and share evidence and field tools currently being used in malaria-endemic countries.

MalariaCare

MalariaCare is a five-year project funded by the US Agency for International Development (USAID) under the US President’s Malaria Initiative (PMI), with the goal of scaling up high-quality diagnosis and case management services for malaria and other febrile (fever causing) illnesses.

MalariaCare is led by PATH and is supported by three other organizations: Medical Care Development International (MCDI), Population Services International (PSI), and Save the Children US.

Read more about what MalariaCare does.
Download the MalariaCare flyer.

NgenIRS

Next Generation Indoor Residual Spraying (NgenIRS) is a partnership between IVCC, the President’s Malaria Initiative, Abt Associates, the Global Fund, PATH, and various national malaria control programs, with the overall aim of accelerating and expanding access to and adoption of new, 3GIRS formulations that are effective against pyrethroid-resistant mosquitoes and increasing the effective lifetime of IRS products. PATH is leading NgenIRS research and evaluation activities in Mozambique, Mali, Ghana, Zambia, and Ethiopia designed to create and disseminate a rigorous evidence base on the health impact and cost effectiveness of new IRS formulations and chemicals in different settings and in combination with other prevention strategies.

Learn more about NgenIRS.